Freshfields and Wachtell steer AstraZeneca/Alexion

Alex Wilts

15 December 2020

Shutterstock/Ascannio

AstraZeneca has tapped Freshfields Bruckhaus Deringer to guide its $39 billion acquisition of Alexion Pharmaceuticals, which is being advised by Wachtell Lipton Rosen & Katz.

Subscribe to Global Competition Review

Subscribe to unlock unlimited access

Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.

Subscribe now

Already have access? Login below

Alex Wilts

View full biography

Author | Editor, GCR USA

[email protected]

Tipline

Drill, baby, drill: The Tipline for 6 October 2022
The Biden Administration’s ambitions for combatting climate change are not aligning with its desire to secure Democratic majorities in Congress. As of next month, the world’s oil cartel is planning on producing 2 million fewer barrels of oil a day. The White House is turning to its strategic reserve and considering lifting sanctions in Venezuela to increase output, but it appears that the Department of Justice’s antitrust division could also be drawn into the …
G’mar chatima tovah: The Tipline for 5 October 2022
Are you not entertained?: The Tipline for 4 October 2022

Freshfields and Wachtell steer AstraZeneca/Alexion

Subscribe to Global Competition Review

Subscribe to unlock unlimited access

Already have access? Login below

Related Topics

Alex Wilts